What is the CVSS score of CVE-2023-50946?

CVE-2023-50946 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N. EPSS exploitation probability: 0.1%.

Which versions of Common Licensing are affected by CVE-2023-50946?

CVE-2023-50946 presents notable security risk, a incorrect authorization vulnerability rated CVSS 6.5. Attackers could gain access beyond their authorized level.

How to fix or mitigate CVE-2023-50946?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Common Licensing CVE-2023-50946

MEDIUM

Incorrect Authorization (CWE-863)

2025-01-26 psirt@us.ibm.com

Authentication Bypass IBM Common Licensing

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

None

Integrity

High

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 28, 2026 - 18:05 vuln.today

CVE Published

Jan 26, 2025 - 16:15 nvd

MEDIUM 6.5

DescriptionCVE.org

IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have access to due to a broken authorization mechanism.

AnalysisAI

IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have access to due to a broken authorization mechanism. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Incorrect Authorization (CWE-863), which allows attackers to bypass authorization checks to access restricted resources. IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have access to due to a broken authorization mechanism. Affected products include: Ibm Common Licensing.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Review and test authorization logic, implement consistent access control checks, use centralized authorization framework.